Dr. Daniel A. Brinton, MD

Dr. Brinton practices at East Bay Retina Consultants, Inc. in Oakland, California.

Dr. Brinton's NPI, 1114919495, was assigned on August 22, 2005. Dr. Brinton graduated from Spencer Fox Eccles School of Medicine in 1982. Dr. Brinton's California license number on file is G057682.

Dr. Brinton's primary practice is East Bay Retina Consultants, Inc., at 3300 Telegraph Ave, Oakland, CA 94609-3028. The practice phone is (510) 444-1600.

Dr. Brinton's primary practice is East Bay Retina Consultants, Inc. in Oakland, California. Dr. Brinton is also affiliated with Alta Bates Summit Medical Center | Alta Bates Campus. The medical group on file is San Joaquin Faculty Medical Group. Dmand AI also links Dr. Brinton to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brinton practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Brinton's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Brinton is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Brinton has a license on file in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, dry eye, glaucoma, hypertensive retinopathy and inflammation of iris among the conditions Dr. Brinton treats.

CMS data shows 10,681 Medicare services from Dr. Brinton across 17 procedure codes in 2024, for 1,141 Medicare patients. Medicare paid $1,108,327 for them.

CMS counts 1,141 Medicare patients who saw Dr. Brinton in 2024. The largest group is 75 to 84, with 442 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brinton's median patient age at 72, with 51% women.

In 2024, Dr. Brinton wrote 271 Medicare Part D claims for 87 patients. 64% of them were for generic drugs. CMS names the drug for 223 of them, across 6 drugs with 11 or more claims each, at $7,032 in total drug cost. In 2023, CMS named 174 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Brinton for performance year 2024, reported as part of a group. Dr. Brinton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Brinton, published from 2019 to 2024. The most frequent topics are Retinal Detachment, Visual Acuity and Cryosurgery. Dr. Brinton has published most often in Am J Ophthalmol. Dr. Brinton's most frequent co-authors are Mark E. Hammer, MD, John C-T Cheng, MD and Douglas R. Fredrick, MD.

Dmand AI links Dr. Brinton to 4 clinical trials, 3 of them phase 3 studies. Conditions studied include Macular Degeneration, Choroidal Neovascularization and Geographic Atrophy.

CMS Open Payments shows 6 general payments to Dr. Brinton from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $123.

Dmand AI lists 12 awards for Dr. Brinton, most recently Honor Award in 1997.

Dr. Brinton graduated from Spencer Fox Eccles School of Medicine in 1982. Dr. Brinton is a member of AAO, ASRS and CMA.

Dr. Brinton is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.